Payment overview · 2025
General Payments
$14.22
1 reported records · 1 companies
Healthcare provider profile · identity verified
Divyesh Purohit, MD
Allopathic & Osteopathic Physicians|Internal Medicine · SHELBURN, IN · NPI 1326028309
Verified facts
What the public records show
CMS Open Payments records show Divyesh Purohit, MD received $14.22 in general payments during 2025 across 1 reported records.
GlaxoSmithKline, LLC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 91 claims for Trelegy Ellipta by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $14.22 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $14.22 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $14.22 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 91 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
91 | 24 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 912 | 178 |
| Atorvastatin Calcium | Atorvastatin Calcium | 839 | 181 |
| Amlodipine Besylate | Amlodipine Besylate | 670 | 146 |
| Lisinopril | Lisinopril | 590 | 129 |
| Gabapentin | Gabapentin | 526 | 111 |
| Alprazolam | Alprazolam | 508 | 45 |
| Omeprazole | Omeprazole | 483 | 120 |
| Pantoprazole Sodium | Pantoprazole Sodium | 462 | 107 |
| Metoprolol Tartrate | Metoprolol Tartrate | 419 | 69 |
| Clopidogrel | Clopidogrel Bisulfate | 406 | 74 |
| Carvedilol | Carvedilol | 404 | 99 |
| Potassium Chloride | Potassium Chloride | 387 | 76 |
| Sertraline Hcl | Sertraline Hcl | 386 | 59 |
| Furosemide | Furosemide | 375 | 76 |
| Tamsulosin Hcl | Tamsulosin Hcl | 364 | 87 |
| Losartan Potassium | Losartan Potassium | 361 | 73 |
| Glimepiride | Glimepiride | 316 | 54 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 284 | 46 |
| Metoprolol Succinate | Metoprolol Succinate | 273 | 68 |
| Famotidine | Famotidine | 270 | 69 |
| Metformin Hcl | Metformin Hcl | 249 | 58 |
| Pravastatin Sodium | Pravastatin Sodium | 242 | 48 |
| Hydrochlorothiazide | Hydrochlorothiazide | 238 | 45 |
| Metformin Hcl Er | Metformin Hcl | 237 | 62 |
| Zolpidem Tartrate | Zolpidem Tartrate | 225 | 36 |
| Ozempic | Semaglutide | 219 | 45 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 211 | 57 |
| Meloxicam | Meloxicam | 198 | 42 |
| Tramadol Hcl | Tramadol Hcl | 198 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 196 | 57 |
| Eliquis | Apixaban | 194 | 44 |
| Montelukast Sodium | Montelukast Sodium | 187 | 50 |
| Trazodone Hcl | Trazodone Hcl | 173 | 41 |
| Allopurinol | Allopurinol | 168 | 44 |
| Azithromycin | Azithromycin | 161 | 127 |
| Donepezil Hcl | Donepezil Hcl | 161 | 33 |
| Duloxetine Hcl | Duloxetine Hcl | 158 | 37 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 152 | 40 |
| Jardiance | Empagliflozin | 145 | 30 |
| Lorazepam | Lorazepam | 142 | 24 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 135 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 135 | 26 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 135 | 30 |
| Simvastatin | Simvastatin | 135 | 33 |
| Celecoxib | Celecoxib | 132 | 35 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 131 | 34 |
| Hydralazine Hcl | Hydralazine Hcl | 120 | 22 |
| Chlorthalidone | Chlorthalidone | 119 | 27 |
| Spironolactone | Spironolactone | 119 | 24 |
| Xarelto | Rivaroxaban | 119 | 22 |
| Pregabalin | Pregabalin | 118 | 21 |
| Farxiga | Dapagliflozin Propanediol | 115 | 22 |
| Meclizine Hcl | Meclizine Hcl | 114 | 24 |
| Clonazepam | Clonazepam | 110 | 16 |
| Memantine Hcl | Memantine Hcl | 109 | 23 |
| Bumetanide | Bumetanide | 108 | 32 |
| Buspirone Hcl | Buspirone Hcl | 106 | 30 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 105 | 65 |
| Prednisone | Prednisone | 104 | 34 |
| Mirtazapine | Mirtazapine | 101 | 14 |
| Tizanidine Hcl | Tizanidine Hcl | 100 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 95 | 31 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 94 | 30 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 91 | 24 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 91 | 50 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 90 | 21 |
| Cefdinir | Cefdinir | 88 | 72 |
| Ezetimibe | Ezetimibe | 85 | 23 |
| Levetiracetam | Levetiracetam | 84 | 11 |
| Ondansetron Hcl | Ondansetron Hcl | 84 | 34 |
| Glipizide | Glipizide | 83 | 13 |
| Methylprednisolone | Methylprednisolone | 81 | 64 |
| Amiodarone Hcl | Amiodarone Hcl | 80 | suppressed |
| Topiramate | Topiramate | 80 | 23 |
| Amitriptyline Hcl | Amitriptyline Hcl | 75 | 17 |
| Baclofen | Baclofen | 75 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 75 | 21 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 71 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 70 | 17 |
| Ropinirole Hcl | Ropinirole Hcl | 69 | 17 |
| Synjardy Xr | Empagliflozin/Metformin Hcl | 65 | 15 |
| Enalapril Maleate | Enalapril Maleate | 64 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 64 | 14 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 61 | 12 |
| Levofloxacin | Levofloxacin | 60 | 45 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 59 | 16 |
| Quetiapine Fumarate | Quetiapine Fumarate | 59 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 58 | suppressed |
| Sucralfate | Sucralfate | 57 | 12 |
| Warfarin Sodium | Warfarin Sodium | 56 | 14 |
| Tradjenta | Linagliptin | 55 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 55 | 18 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 54 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 53 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 53 | 15 |
| Levemir Flexpen | Insulin Detemir | 53 | 12 |
| Cephalexin | Cephalexin | 52 | 40 |
| Finasteride | Finasteride | 52 | 16 |
| Nebivolol Hcl | Nebivolol Hcl | 52 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 50 | 14 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 50 | 39 |
| Bupropion Xl | Bupropion Hcl | 48 | 11 |
| Olanzapine | Olanzapine | 47 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 47 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 44 | 35 |
| Nortriptyline Hcl | Nortriptyline Hcl | 44 | suppressed |
| Diazepam | Diazepam | 43 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 43 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 42 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 41 | 11 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 41 | 12 |
| Lovastatin | Lovastatin | 41 | 12 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 41 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 40 | suppressed |
| Januvia | Sitagliptin Phosphate | 39 | suppressed |
| Torsemide | Torsemide | 39 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 39 | 12 |
| Fluconazole | Fluconazole | 38 | 22 |
| Nitroglycerin | Nitroglycerin | 38 | 25 |
| Nystatin | Nystatin | 37 | 18 |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 36 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 36 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 36 | suppressed |
| Trulicity | Dulaglutide | 36 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 35 | 11 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 35 | 14 |
| Mounjaro | Tirzepatide | 35 | suppressed |
| Valsartan | Valsartan | 35 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | suppressed |
| Myrbetriq | Mirabegron | 34 | suppressed |
| Mupirocin | Mupirocin | 33 | 22 |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 33 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 32 | 17 |
| Divalproex Sodium | Divalproex Sodium | 32 | suppressed |
| Nabumetone | Nabumetone | 32 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 32 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 31 | suppressed |
| Xigduo Xr | Dapaglifloz Propaned/Metformin | 31 | suppressed |
| Acyclovir | Acyclovir | 30 | 17 |
| Fenofibrate | Fenofibrate | 30 | suppressed |
| Aripiprazole | Aripiprazole | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 29 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 28 | suppressed |
| Loperamide | Loperamide Hcl | 28 | 13 |
| Methocarbamol | Methocarbamol | 28 | suppressed |
| Atenolol | Atenolol | 27 | suppressed |
| Colchicine | Colchicine | 26 | suppressed |
| Eszopiclone | Eszopiclone | 26 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 25 | 22 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 25 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 25 | suppressed |
| Risperidone | Risperidone | 25 | suppressed |
| Entresto | Sacubitril/Valsartan | 24 | suppressed |
| Rybelsus | Semaglutide | 24 | suppressed |
| Amoxicillin | Amoxicillin | 23 | 20 |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 23 | suppressed |
| Metolazone | Metolazone | 23 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 23 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 21 | suppressed |
| Estradiol | Estradiol | 21 | suppressed |
| Ibuprofen | Ibuprofen | 21 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 21 | suppressed |
| Clonidine | Clonidine | 20 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 20 | suppressed |
| Novolog | Insulin Aspart | 20 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 19 | suppressed |
| Glipizide Er | Glipizide | 19 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 19 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 19 | suppressed |
| Cilostazol | Cilostazol | 18 | suppressed |
| Creon | Lipase/Protease/Amylase | 18 | suppressed |
| Dutasteride | Dutasteride | 18 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Lubiprostone | Lubiprostone | 18 | suppressed |
| Testosterone | Testosterone | 18 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 17 | suppressed |
| Gvoke Hypopen 1-Pack | Glucagon | 17 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 17 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 17 | suppressed |
| Pen Needle | Pen Needle, Diabetic | 17 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Acetazolamide | Acetazolamide | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Hydrocortisone | Hydrocortisone | 15 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 15 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Humulin N | Insulin Nph Human Isophane | 14 | suppressed |
| Modafinil | Modafinil | 14 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 14 | suppressed |
| Oxaprozin | Oxaprozin | 14 | suppressed |
| Premarin | Estrogens, Conjugated | 14 | suppressed |
| Saxagliptin Hcl | Saxagliptin Hcl | 14 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 13 | suppressed |
| Indomethacin | Indomethacin | 13 | suppressed |
| Klor-Con M20 | Potassium Chloride | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Ranolazine Er | Ranolazine | 13 | suppressed |
| Rexulti | Brexpiprazole | 13 | suppressed |
| Rytary | Carbidopa/Levodopa | 13 | suppressed |
| Soliqua 100-33 | Insulin Glargine/Lixisenatide | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Benazepril-Hydrochlorothiazide | Benazepril/Hydrochlorothiazide | 12 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 12 | suppressed |
| Digoxin | Digoxin | 12 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 12 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | 12 |
| Lamotrigine | Lamotrigine | 12 | suppressed |
| Novolog Flexpen | Insulin Aspart | 12 | suppressed |
| Ofloxacin | Ofloxacin | 12 | suppressed |
| Tramadol Hcl-Acetaminophen | Tramadol Hcl/Acetaminophen | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 11 | suppressed |
| Carbamazepine Er | Carbamazepine | 11 | suppressed |
| Folic Acid | Folic Acid | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Latanoprost | Latanoprost | 11 | suppressed |
| Linzess | Linaclotide | 11 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Probenecid-Colchicine | Probenecid/Colchicine | 11 | suppressed |
| Tramadol Hcl Er | Tramadol Hcl | 11 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $14.22 · 1 records | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error